Nobelis Group Black Eyeliner Pencil High Impact 1 Unit
Nobelis Group Black Eyeliner Pencil High Impact 1 Unit
Couldn't load pickup availability
Clinique's High Impact Eye Pencil, 2.8g, is designed to define and intensify the eyes while providing precise and comfortable application. Its creamy texture allows for a clean, buildable line, suitable for all skin types, even sensitive.
- Formula tested under ophthalmological control, suitable for sensitive eyes and contact lens wearers
- Soft and long-lasting texture, easy to blend for different makeup styles
Apply the High Impact Eye Pencil along the upper or lower lash line, depending on the desired effect. For a more intense result, reapply or blend with a suitable brush. Remove makeup thoroughly at the end of the day with a suitable eye makeup remover. Follow the precautions for use indicated in the manufacturer's instructions.
Cyclopentasiloxane, Trimethylsiloxysilicate, Synthetic Wax, Polyethylene, Caprylyl Methicone, Disteardimonium Hectorite, Propylene Carbonate, Tocopherol, Ascorbyl Palmitate, Lecithin, Citric Acid, [+/- : CI 77499, CI 77491, CI 77492, CI 77891, Mica, CI 77510, CI 77007, CI 77288, CI 77289]. For the full list of ingredients, see package insert.
Legal notices:
The information on this product sheet is provided for information purposes only, in accordance with Regulation (EC) No. 1924/2006 on nutrition and health claims made on foodstuffs, and Article L. 111-1 of the French Consumer Code.
They cannot in any case constitute a medical prescription nor replace the consultation of a qualified health professional. Any use of the product must comply with the instructions, the recommended dosage, and the precautions for use.
In accordance with Article L. 5122-15 of the Public Health Code, all liability is declined in the event of misuse, self-medication or non-compliance with official recommendations.
Photographs, descriptions, and technical information are non-contractual and are subject to change at any time. The user is encouraged to regularly check for updates or contact a healthcare professional for any treatment-related questions.
Share
